CC BY-NC-ND 4.0 · Indian Journal of Neurotrauma 2020; 17(01): 37-41
DOI: 10.1055/s-0040-1713457
Review Article

Mitochondrial Dysfunction in Traumatic Brain Injury: Management Strategies

Carlos-Andrés Bonilla-Mendoza
1  Centro de Investigaciones Biomédicas (CIB), Faculty of Medicine, University of Cartagena, Cartagena, Columbia
,
Ezequiel Garcia-Ballestas
1  Centro de Investigaciones Biomédicas (CIB), Faculty of Medicine, University of Cartagena, Cartagena, Columbia
,
Alfonso Pacheco-Hernandez
2  Fundación Centro Colombiano de Epilepsia y Enfermedades Neurologicas–FIRE, Faculty of Medicine, University of Cartagena, Cartagena, Columbia
,
Luis-Rafael Moscote-Salazar
3  Centro de Investigaciones Biomedicas (CIB), Cartagena Neurotrauma Research Group Research Line, Faculty of Medicine, University of Cartagena, Cartagena, Columbia
,
Ravish R. Keni
4  Department of Neurology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India
,
Amit Agrawal
5  Department of Neurosurgery, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India
› Author Affiliations
  

Abstract

Today, traumatic brain injuries continue to be studied, increasingly investigating the pathophysiological mechanisms that contribute to the clinical presentation, severity, and possible sequelae, but despite this, the prognosis of these patients is sometimes poor. Mitochondrial dysfunction comprises a series of reactions that contribute to the inflammatory process in these patients that have an impact on the prognosis, since it is one of the pathophysiological mechanisms involved in secondary lesions after a traumatic brain injury; and therefore has opened a field of study in the search of possible biomolecular markers that allow us to establish a prognosis and prediction of mortality.



Publication History

Publication Date:
11 August 2020 (online)

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India